Kearney Terrence C
Insider CIK 1289098 · THRX Director · XLRN Director · AVXS Director · VRTX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| VRTX VERTEX PHARMACEUTICALS INC | A Award deriv | 2024-05-01 | 2024-05-03 | 3,142 | — | $0 | 3,142 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2023-08-10 | 2023-08-14 | 10,000 | — | $0 | 10,000 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2023-08-10 | 2023-08-14 | 10,000 | $350.00 | $3.50M | 6,536 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2023-08-10 | 2023-08-14 | 10,000 | $127.54 | $1.28M | 16,536 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award deriv | 2023-05-01 | 2023-05-03 | 3,481 | — | $0 | 3,481 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award deriv | 2022-05-01 | 2022-05-03 | 2,231 | — | $0 | 2,231 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2022-05-01 | 2022-05-03 | 725 | — | $0 | 6,536 | SEC↗ |
| XLRN ACCELERON PHARMA INC | D To issuer deriv | 2021-11-19 | 2021-11-22 | 7,500 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | D To issuer deriv | 2021-11-19 | 2021-11-22 | 3,222 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | D To issuer deriv | 2021-11-19 | 2021-11-22 | 4,665 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | D To issuer deriv | 2021-11-19 | 2021-11-22 | 7,500 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | D To issuer deriv | 2021-11-19 | 2021-11-22 | 8,185 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | U Tender | 2021-11-19 | 2021-11-22 | 6,749 | — | $0 | 0 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award deriv | 2021-05-01 | 2021-05-04 | 6,067 | — | $0 | 6,067 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2021-01-29 | 2021-02-02 | 3,222 | — | $0 | 3,222 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award | 2021-01-29 | 2021-02-02 | 1,622 | — | $0 | 6,749 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2020-10-12 | 2020-10-13 | 10,000 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2020-10-12 | 2020-10-13 | 20,000 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2020-10-12 | 2020-10-13 | 7,500 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2020-10-12 | 2020-10-13 | 913 | $120.57 | $110.1K | 5,127 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2020-10-12 | 2020-10-13 | 10,000 | $27.97 | $279.7K | 35,127 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2020-10-12 | 2020-10-13 | 20,000 | $28.37 | $567.4K | 25,127 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2020-10-12 | 2020-10-13 | 16,210 | $119.78 | $1.94M | 6,040 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2020-10-12 | 2020-10-13 | 18,177 | $119.11 | $2.17M | 22,250 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2020-10-12 | 2020-10-13 | 2,200 | $117.82 | $259.2K | 40,427 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2020-10-12 | 2020-10-13 | 7,500 | $30.17 | $226.3K | 42,627 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award deriv | 2020-06-01 | 2020-06-03 | 4,527 | — | $0 | 4,527 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2020-01-22 | 2020-01-24 | 8,185 | — | $0 | 8,185 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award | 2020-01-22 | 2020-01-24 | 1,377 | — | $0 | 5,127 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2019-11-01 | 2019-11-04 | 20,000 | — | $0 | 0 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2019-11-01 | 2019-11-04 | 375 | — | $0 | 0 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2019-11-01 | 2019-11-04 | 7,073 | — | $0 | 0 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2019-11-01 | 2019-11-04 | 20,000 | — | $0 | 0 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2019-11-01 | 2019-11-04 | 7,073 | $200.00 | $1.41M | 5,811 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2019-11-01 | 2019-11-04 | 7,073 | $93.51 | $661.4K | 12,884 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2019-11-01 | 2019-11-04 | 20,000 | $200.00 | $4.00M | 5,811 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2019-11-01 | 2019-11-04 | 20,000 | $72.14 | $1.44M | 25,811 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2019-11-01 | 2019-11-04 | 375 | $200.00 | $75.0K | 5,811 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2019-11-01 | 2019-11-04 | 375 | $56.99 | $21.4K | 6,186 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2019-11-01 | 2019-11-04 | 20,000 | $200.00 | $4.00M | 5,811 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2019-11-01 | 2019-11-04 | 20,000 | $81.54 | $1.63M | 25,811 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2019-11-01 | 2019-11-04 | 3,159 | $200.00 | $631.8K | 5,811 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2019-10-31 | 2019-11-04 | 1,841 | $200.00 | $368.2K | 8,970 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2019-06-01 | 2019-06-04 | 2,381 | — | $0 | 10,811 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2019-01-25 | 2019-01-29 | 7,500 | — | $0 | 7,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award | 2019-01-25 | 2019-01-29 | 1,250 | — | $0 | 3,750 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award deriv | 2018-06-01 | 2018-06-05 | 3,229 | — | $0 | 3,229 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2018-06-01 | 2018-06-05 | 1,801 | — | $0 | 8,430 | SEC↗ |
| AVXS AveXis, Inc. | D To issuer deriv | 2018-05-15 | 2018-05-15 | 2,905 | — | $0 | 0 | SEC↗ |
| AVXS AveXis, Inc. | D To issuer deriv | 2018-05-15 | 2018-05-15 | 2,454 | — | $0 | 0 | SEC↗ |
| AVXS AveXis, Inc. | D To issuer deriv | 2018-05-15 | 2018-05-15 | 26,496 | — | $0 | 0 | SEC↗ |
| AVXS AveXis, Inc. | D To issuer | 2018-05-15 | 2018-05-15 | 1,106 | — | $0 | 0 | SEC↗ |
| AVXS AveXis, Inc. | A Award deriv | 2018-03-13 | 2018-03-30 | 2,905 | — | $0 | 2,905 | SEC↗ |
| AVXS AveXis, Inc. | A Award | 2018-03-13 | 2018-03-30 | 1,106 | — | $0 | 1,106 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2018-03-01 | 2018-03-05 | 7,500 | — | $0 | 7,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award | 2018-03-01 | 2018-03-05 | 1,250 | — | $0 | 2,500 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2017-06-01 | 2017-06-05 | 5,295 | — | $0 | 5,295 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2017-06-01 | 2017-06-05 | 2,188 | — | $0 | 6,629 | SEC↗ |
| AVXS AveXis, Inc. | A Award deriv | 2017-05-30 | 2017-06-01 | 2,454 | — | $0 | 2,454 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2017-03-02 | 2017-03-14 | 7,500 | — | $0 | 7,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award | 2017-03-02 | 2017-03-14 | 1,250 | — | $0 | 1,250 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award deriv | 2016-06-01 | 2016-06-03 | 7,073 | — | $0 | 7,073 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2016-06-01 | 2016-06-03 | 2,941 | $0.01 | $29 | 4,441 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2016-03-03 | 2016-03-07 | 10,000 | — | $0 | 10,000 | SEC↗ |
| AVXS AveXis, Inc. | A Award deriv | 2016-02-10 | 2016-02-12 | 18,111 | — | $0 | 18,111 | SEC↗ |
| AVXS AveXis, Inc. | A Award deriv | 2016-02-10 | 2016-02-12 | 8,385 | — | $0 | 8,385 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award deriv | 2015-06-01 | 2015-06-03 | 20,000 | — | $0 | 20,000 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2015-05-19 | 2015-05-21 | 1,500 | — | $0 | 375 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2015-05-19 | 2015-05-21 | 1,500 | $56.99 | $85.5K | 1,500 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2015-04-27 | 2015-04-29 | 28,125 | — | $0 | 1,875 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2015-04-27 | 2015-04-29 | 20,000 | — | $0 | 0 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2015-04-27 | 2015-04-29 | 20,000 | — | $0 | 0 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2015-04-27 | 2015-04-29 | 2,300 | $133.63 | $307.3K | 0 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2015-04-27 | 2015-04-29 | 3,969 | $131.76 | $523.0K | 7,968 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2015-04-27 | 2015-04-29 | 8,800 | $130.58 | $1.15M | 11,937 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2015-04-27 | 2015-04-29 | 4,500 | $129.94 | $584.7K | 20,737 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2015-04-27 | 2015-04-29 | 16,295 | $128.12 | $2.09M | 25,237 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2015-04-27 | 2015-04-29 | 5,668 | $132.82 | $752.8K | 2,300 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2015-04-27 | 2015-04-29 | 28,125 | $56.99 | $1.60M | 28,125 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2015-04-27 | 2015-04-29 | 26,593 | $127.50 | $3.39M | 41,532 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2015-04-27 | 2015-04-29 | 20,000 | $53.85 | $1.08M | 48,125 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2015-04-27 | 2015-04-29 | 20,000 | $59.55 | $1.19M | 68,125 | SEC↗ |
| THRX THERAVANCE INC | A Award | 2015-04-24 | 2015-04-27 | 13,950 | — | $0 | 37,083 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2015-01-08 | 2015-04-08 | 4,665 | — | $0 | 4,665 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2015-01-08 | 2015-01-09 | 4,665 | — | $0 | 4,665 | SEC↗ |
| THRX THERAVANCE INC | A Award | 2014-10-30 | 2014-11-03 | 23,133 | — | $0 | 23,133 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2014-07-14 | 2014-07-16 | 20,000 | — | $0 | 20,000 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award deriv | 2014-06-01 | 2014-06-03 | 20,000 | — | $0 | 20,000 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award deriv | 2013-06-01 | 2013-06-04 | 20,000 | — | $0 | 20,000 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award deriv | 2012-06-01 | 2012-06-01 | 20,000 | — | $0 | 20,000 | SEC↗ |